Sharing Progress in Cancer Care Interview with the Expert: Brian Druker

Sep 10

Aleksandra Filipovic, Scientific Clinical Advisor at SPCC, recently interviewed Dr. Brian Druker, the esteemed director of the OHSU Knight Cancer Institute. Known for his groundbreaking work in cancer research, Dr. Druker developed Gleevec, a targeted therapy that revolutionised the treatment of chronic myeloid leukemia (CML) by attacking cancer cells while preserving healthy ones. In the interview, Dr. Druker also reflects on the key milestones of his life and career, from his early days to his present work.

Aleksandra Filipovic

The neuroplasticity you develop in practicing this way of being, where you consciously choose not to internalize your outer world, and the tools you learn to use on a daily basis to help you achieve this, are priceless. We teach this at H.E.A.L.

Th

Any pattern in life that you desire to shift out of first needs to be released from the body.

🔸 Are you tired of repeating patterns in your life? In relationships, at work, with family?

🔸 Are you making resolutions to start a new nutrition or ex

© 2024 H.E.A.L Clinic/Aleksandra Filipovic  |  GRAPHIC DESIGN BY Miloš Aleksić  |  PHOTOS BY Yolande de Vries  |  SITE BY WELL SITES

Sharing Progress in Cancer Care Interview with the Expert: Brian Druker

The Biohacking Blondes: The Role of Belief Systems in Cancer Recovery with Dr. Aleksandra Flipovic

Impact 2024 Fireside Chat: Screening and Proper Diagnostics - Key Success Factors for a Healthier Society